Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Sunpeaks Ventures, Inc. (OTCBB: SNPK) Featured By Small Cap Investment Research

(EMAILWIRE.COM, April 11, 2012 ) Los Angeles, CA -- Small Cap Investment Research (, a developer, publisher and marketer of independent research products, announced today the release of an updated research report on Sunpeaks Ventures, Inc (OTCBB: SNPK) (“the Company”). Small Cap Investment Research has issued a “STRONG BUY” and a target price of $9.00 on shares of this company.

The report examines the potential continued growth of the Company as it continues to gain market share, and examines the outlook for short and long-term investors. “We were pleased to have the opportunity to report on this company and the industry factors that affect it. The report presents a great overview of the Company and its potential for the long-term with a constantly improving industry dynamic.” – Small Cap Investment Research.

Recently, Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") announced that HDS has signed a Letter of Intent with PharmaLife® for placement of Clotamin® with leading pharmacies in the Russian Federation.

The Letter of Intent outlines the terms and conditions of a proposed transaction that could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation, including product placement with leading wholesalers Imperia-Pharma, the Dr. Stoletov pharmacy chain (414 locations), and other small retail pharmacies associated with Imperia-Pharma. PharmaLife is also expected to secure timely product registration within the Russian Federation for Clotamin distribution and conduct local market research to support a successful product launch.

The entire report can be found on .

About Small Cap Investment Research:

Small Cap Investment Research specializes in providing readers with an in-depth analysis of undervalued companies. The company’s role as an independent research analyst firm is to “separate the wheat from the chaff” and help investors receive unbiased, thought-provoking, and quality investment research. SCIR’s philosophy in research is to encapsulate realistic investment ratings, target prices, and forward-looking financial models. The reports contain hard-hitting, meticulously researched facts on companies, their fundamentals, and their industries, validating a company’s prospects and enabling the reader to objectively evaluate the company’s value. The media and savvy investors alike view this model as how investment research needs to be performed devoid of any partiality.

About Sunpeaks Ventures, Inc.:

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.

Forward-Looking Statements

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of Sunpeaks Ventures, Inc. (OTCBB: SNPK) can be found in the filings of Sunpeaks Ventures, Inc. with the U.S. Securities and Exchange Commission.

Release of Liability: Through use of this website viewing or using you agree to hold SCIR, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. We have been compensated six thousand dollars for this SNPK report. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SCIR encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SCIR makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.

Indepedent Research Investment
Derrick Brazinski


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

Type of weight loss surgery matters for diabetes remission
6 Oct 2015 at 10:13pm
By Lisa Rapaport (Reuters Health) - Diabetics considering weight-loss surgery to help send their disease into remission should opt for the most popular procedure, a gastric bypass, researchers suggest. In their study of different types of so-called bariatric surgeries, the biggest impact on diabetes remission was seen with gastric bypass, which can reduce the size of the stomach from about three pints to roughly the size of a shot glass. The researchers studied 569 obese patients with type 2 diabetes who had different types of weight-loss operations and 1,881 similar diabetics who didn?t have surgery.

Weight loss, exercise may boost fertility odds for women with PCOS
6 Oct 2015 at 10:10pm

By Lisa Rapaport (Reuters Health) - Women who suffer from a leading cause of infertility may increase their odds of conception if they exercise and lose weight, a U.S. study suggests. Researchers compared pregnancy outcomes for 150 women with polycystic ovary syndrome (PCOS), a condition that occurs when the female body makes higher than normal amounts of testosterone and androgens, sex hormones associated with male traits. Women with PCOS often experience irregular menstrual cycles, weight gain, excess hair on the face and body and infertility.

Nearly 700 killed by dengue in Brazil: health officials
6 Oct 2015 at 6:25pm

Health officials in Brazil said a record 693 people have died so far this year after contracting dengue fever, the deadly mosquito-borne disease running rampant across Central and South America. Most of the deaths occurred in Sao Paulo state, according to a statement from the federal health ministry, which said the deaths were the highest since 1990, when officials began compiling records tracking the number of people infected with the ailment. The actual number of fatalities is presumably higher, since the official figure reflects deaths in Brazil from dengue from the beginning of the year just through the end of August.

Right-to-die backers say California helps fight elsewhere
6 Oct 2015 at 4:54pm

SAN DIEGO (AP) ? It will soon be legal for the terminally ill to end their own lives in the nation's most populous state, and right-to-die advocates expect other states to follow California's example.

Transplanting ovarian tissue helps some women have babies
6 Oct 2015 at 4:23pm

LONDON (AP) ? The biggest study ever of women who had ovarian tissue removed, frozen and transplanted suggests the experimental technique is safe and can help about one third of them to have babies.

Obama makes pitch to win support for Pacific trade pact
6 Oct 2015 at 4:10pm

By Krista Hughes and Roberta Rampton WASHINGTON (Reuters) - U.S. President Barack Obama kicked off a sales pitch on Tuesday for a 12-nation Pacific Rim trade agreement, urging farmers to push their lawmakers to approve what he said would boost their sales in a fast-growing region. Obama was upbeat about winning support in the Republican-controlled Congress for the pact, which was announced early Monday. "Ultimately we?re going to get this done, and it will be an enormous achievement for us to be able to make sure that 40 percent of the world?s economy is operating under rules that don?t hurt us," Obama told agricultural and business leaders gathered at the U.S. Agriculture Department.

Post-war trauma endangers peacebuilding, economic growth: experts
6 Oct 2015 at 4:03pm
By Alex Whiting LONDON (Thomson Reuters Foundation) - Traumatized by his experiences as a child soldier in South Sudan, 14-year-old Peter decided to settle an argument with two other children by taking an AK-47 from the local military barracks to shoot them. Peter, whose name has been changed to protect his identity, was one of nearly 1,800 children being reintegrated into their communities after their release earlier this year from the South Sudan Democratic Army Cobra Faction in eastern Jonglei state. Counselor Shaun Collins, who has recently returned to Britain after six months as a leader on the U.N. children's agency (UNICEF) program which helped release and reintegrate the children, decided to not to offer Peter formal therapy.

Lawsuit over DuPont Teflon-making chemical C8 goes to jury
6 Oct 2015 at 3:52pm

By Kathy Lynn Gray COLUMBUS, Ohio (Reuters) - The first lawsuit against DuPont by a cancer patient who claims her disease was linked to a chemical used in the making of Teflon went to jurors at a U.S. federal court in Ohio on Tuesday after three weeks of testimony. Plaintiff Carla M. Bartlett is trying to prove that C8, which leached into drinking water near one of DuPont's plants in West Virginia, gave her kidney cancer and that DuPont's recklessness is to blame.

Montana judge rules lethal injection drug violates state law
6 Oct 2015 at 3:42pm
(Reuters) - A Montana judge ruled on Tuesday that one of the drugs planned for use in a lethal injection mix violates state law, effectively putting a hold on executions in the state, which has only two inmates on death row.

Futuristic Device Fixes Holes In The Heart Without Invasive Surgery
6 Oct 2015 at 3:10pm

Scientists in Boston have come up with an ingenious new way to repair life-threatening holes in patients' hearts and other organs.Instead of invasive surgery and the risk that entails, the new technique makes use of an ultraviolet-light-enabled catheter that patches the holes using a plug made of a biodegradable, light-activated...

Express Scripts sees $750 million in spending on new cholesterol drugs
6 Oct 2015 at 3:06pm
Express Scripts Holding Co, the largest manager of prescription drug plans for U.S. employers and health plans, said it has reached deals to cover two costly new cholesterol drugs and expects to spend no more than $750 million on them next year. The injected drugs - Repatha from Amgen Inc and Praluent from partners Regeneron Pharmaceuticals Inc and Sanofi - each have list prices of more than $14,000 a year. Express Scripts, which has been a vocal critic of rising U.S. drug prices, would not comment on how much of a discount it had negotiated.

Factors in middle school tied to impaired driving later on
6 Oct 2015 at 3:05pm
By Andrew M. Seaman (Reuters Health) - Risk factors for intoxicated driving in high school, or for riding with impaired drivers, may be evident in children as young as 12, a new study suggests. Middle-schoolers with positive attitudes toward marijuana or recent alcohol use, for example, were at increased risk of driving under the influence and riding with drinking drivers as teens, the authors found. Regular conversations with adolescents may help parents and caregivers identify the youngsters who are at risk, said senior author Elizabeth D'Amico, of the RAND Corporation in Santa Monica, California.

GE probing similar engine parts in wake of BA plane fire
6 Oct 2015 at 2:47pm

(Reuters) - General Electric Co said on Tuesday it was inspecting out-of-service versions of the engine component involved in a fire with a British Airways plane last month to further determine the cause of the engine failure. The National Transportation Safety Board (NTSB) said last month that a failure in the plane's GE90 engine was not contained by the engine's casing and that it had found several pieces of the high pressure compressor spool on the runway. In an update to the investigation on Tuesday, the NTSB said that a spool in the high-pressure compressor section of the engine had failed.

AmerisourceBergen to buy PharMEDium for $2.58 billion
6 Oct 2015 at 2:23pm
(Reuters) - Drug distributor AmerisourceBergen Corp agreed to buy PharMEDium Healthcare Holdings Inc for $2.58 billion from private equity firm Clayton, Dubilier & Rice, expanding its business of supplying compounded drugs to hospitals. Compounding is a process in which pharma products are diluted to create doses that are not sold commercially. Increased regulatory oversight following a fungal meningitis outbreak at a compounding pharmacy in 2012 has escalated the costs for hospitals to produce compounded products internally, boosting demand for large-scale firms such as PharMEDium. ...

Family Looks Back at Brittany Maynard???s Fight After California ???Death Wit...
6 Oct 2015 at 2:23pm
Brittany Maynard died last year after bringing attention to ???aid-in-dying??? legislation. is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.

GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | | i-Canada-News.Com | | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | | | | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | - Medicl Newswire and Press Release service of GroupWeb Media LLC